Casirivimab/Imdevimab May Be Significantly Protective Against COVID-19
Researchers assessed the safety and efficacy of subcutaneous casirivimab/imdevimab for the prevention of COVID-19 infection.
Researchers assessed the safety and efficacy of subcutaneous casirivimab/imdevimab for the prevention of COVID-19 infection.
Researchers assessed the efficacy of corticosteroids for the treatment of COVID-19 infection.
COVID-19 outcomes in patients with dermatomyositis are compared with those of the general population.
Researchers compared immune responses following COVID-19 vaccination with the mRNA-1273 vs the BNT162b2 vaccines among patients with rheumatic and musculoskeletal diseases and solid organ transplant recipients.
Investigators compared treatment with interleukin-6 inhibitors with standard of care among patients hospitalized with COVID-19 infection.
The effectiveness of risankizumab (RZB) in treating fingernail psoriasis in patients with psoriatic arthritis is reported.
A study examines the relationship between serum chemerin and disease activity in women with rheumatoid arthritis (RA).
Incidence of, and risk factors for, lumbar lesions in RA are examined in a longitudinal study.
Does local joint swelling recur in the same joints in patients with rheumatoid arthritis?
The efficacy and safety of filgotinib in methotrexate-naïve patients with RA with poor prognostic factors is examined.